文献速递临床试验与 GCP真实世界研究与卫生经济

减少体重的社交移动方法(SMART)2.0:大学环境中年轻成人随机对照试验方案

Social Mobile Approaches to Reducing Weight (SMART) 2.0: protocol of a randomized controlled trial among young adults in university settings.
PubMed 文献 · Trials · 2022-01-03

SMART 2.0 是一项为期24个月的平行组随机对照试验,计划纳入642名18-35岁超重或肥胖的大学与社区学院参与者。所有参与者获得可穿戴活动追踪器、联网体重秤及相应应用程序;两个干预组在此基础上接受个性化每日短信、社交媒体帖子和在线小组等干预,其中一组额外接受技术介导的简短健康指导。主要结局为24个月内客观测量的体重(千克),采用重复测量混合模型并按意向性治疗原则分析。

要点

  • SMART 2.0 为24个月平行组随机对照试验,计划纳入642名18-35岁超重或肥胖的大学与社区学院参与者。
  • 所有参与者获得可穿戴活动追踪器、联网体重秤及相应应用程序;两个干预组额外接受个性化短信、社交媒体和在线小组干预,其中一组再加健康指导。
  • 主要结局为24个月内客观测量的体重(千克),采用重复测量混合模型并按意向性治疗原则分析。

核心结论

  • 作者假设两个SMART 2.0干预组相比对照组将显著改善体重减轻,且接受健康指导的组将获得最大改善。
  • 作者进一步假设次要结局的差异将有利于干预组。

研究设计与样本

  • SMART 2.0研究是一项24个月平行组随机对照试验,计划纳入642名来自加利福尼亚州圣迭戈大学与社区学院的18-35岁超重或肥胖参与者。
  • 所有参与者获得可穿戴活动追踪器、联网体重秤及相应应用程序。
  • 随机至第一干预组的参与者通过个性化每日短信(即SMS/MMS)、社交媒体平台帖子和在线小组接受基于证据的体重减轻与行为改变技术信息。
  • 随机至第二干预组的参与者除上述要素外,还接受技术介导的简短健康指导。
  • 对照组参与者仅获得可穿戴活动追踪器、联网体重秤及相应应用程序。

主要发现

  • 主要结局为24个月内客观测量的体重(千克)。
  • 次要结局包括人体测量指标、生理指标、身体活动、饮食、睡眠和心理社会指标,以及对干预模式的参与度。
  • 结局在基线及6、12、18和24个月时评估。
  • 随机组间差异将采用重复测量混合模型分析,并基于意向性治疗原则。

临床怎么用

  • 作者认为需要在年轻成人中推进对多模式、技术为基础且具有长期效果和广泛传播潜力的体重减轻干预措施有效性的理解。
  • 作者认为其发现应能为实施低成本、可扩展的体重减轻和降低风险健康行为干预提供信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Excess weight gain in young adulthood is associated with future weight gain and increased risk of chronic disease. Although multimodal, technology-based weight-loss interventions have the potential to promote weight loss among young adults, many interventions have limited personalization, and few have been deployed and evaluated for longer than a year. We aim to assess the effects of a highly personalized, 2-year intervention that uses popular mobile and social technologies to promote weight loss among young adults. METHODS: The Social Mobile Approaches to Reducing Weight (SMART) 2.0 Study is a 24-month parallel-group randomized controlled trial that will include 642 overweight or obese participants, aged 18-35 years, from universities and community colleges in San Diego, CA. All participants receive a wearable activity tracker, connected scale, and corresponding app. Participants randomized to one intervention group receive evidence-based information about weight loss and behavior change techniques via personalized daily text messaging (i.e., SMS/MMS), posts on social media platforms, and online groups. Participants in a second intervention group receive the aforementioned elements in addition to brief, technology-mediated health coaching. Participants in the control group receive a wearable activity tracker, connected scale, and corresponding app alone. The primary outcome is objectively measured weight in kilograms over 24 months. Secondary outcomes include anthropometric measurements; physiological measures; physical activity, diet, sleep, and psychosocial measures; and engagement with intervention modalities. Outcomes are assessed at baseline and 6, 12, 18, and 24 months. Differences between the randomized groups will be analyzed using a mixed model of repeated measures and will be based on the intent-to-treat principle. DISCUSSION: We hypothesize that both SMART 2.0 intervention groups will significantly improve weight loss compared to the control group, and the group receiving health coaching will experience the greatest improvement. We further hypothesize that differences in secondary outcomes will favor the intervention groups. There is a critical need to advance understanding of the effectiveness of multimodal, technology-based weight-loss interventions that have the potential for long-term effects and widespread dissemination among young adults. Our findings should inform the implementation of low-cost and scalable interventions for weight loss and risk-reducing health behaviors. TRIAL REGISTRATION: ClinicalTrials.gov NCT03907462 . Registered on April 9, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mansour-Assi SJ, Golaszewski NM, Costello VL, et al. Social Mobile Approaches to Reducing Weight (SMART) 2.0: protocol of a randomized controlled trial among young adults in university settings. Trials. 2022. PMID: 34980208. doi:10.1186/s13063-021-05938-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。